Addus HomeCare Co. (NASDAQ:ADUS) Director Esteban Lopez Sells 500 Shares

Addus HomeCare Co. (NASDAQ:ADUS) Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares in the company, valued at $429,165. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Esteban Lopez also recently made the following trade(s):

• On Wednesday, September 4th, Esteban Lopez sold 500 shares of Addus HomeCare stock. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00.

Addus HomeCare Price Performance

Shares of ADUS opened at $128.40 on Friday. Addus HomeCare Co. has a 12 month low of $78.35 and a 12 month high of $134.78. The stock has a market cap of $2.32 billion, a PE ratio of 31.86, a P/E/G ratio of 2.31 and a beta of 1.04. The stock’s 50-day moving average is $125.52 and its two-hundred day moving average is $112.41.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. During the same quarter in the prior year, the business earned $0.94 EPS. Addus HomeCare’s quarterly revenue was up 10.4% compared to the same quarter last year. On average, research analysts anticipate that Addus HomeCare Co. will post 4.53 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in Addus HomeCare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock worth $131,910,000 after buying an additional 19,027 shares during the period. Wellington Management Group LLP increased its position in shares of Addus HomeCare by 1.2% during the fourth quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock worth $74,135,000 after acquiring an additional 9,548 shares during the last quarter. Point72 Asset Management L.P. lifted its stake in shares of Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after acquiring an additional 315,602 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after purchasing an additional 5,421 shares during the last quarter. Finally, Principal Financial Group Inc. grew its stake in Addus HomeCare by 20.9% during the 2nd quarter. Principal Financial Group Inc. now owns 430,444 shares of the company’s stock valued at $49,979,000 after purchasing an additional 74,488 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Stephens reaffirmed an “overweight” rating and set a $138.00 price target on shares of Addus HomeCare in a research report on Tuesday, August 6th. TD Cowen upped their price objective on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Oppenheimer lifted their target price on Addus HomeCare from $130.00 to $140.00 and gave the company an “outperform” rating in a report on Wednesday, August 7th. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. Finally, Macquarie initiated coverage on Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 price objective on the stock. One investment analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $127.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.